CLOV vs KRYS
Clover Health Investments Corp (CLOV) versus Krystal Biotech Inc (KRYS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported KRYS revenue for 2024-12-31 was $290.5M. Net income was $89.2M. Revenue was up 473.0% from 2023-12-31 to 2024-12-31. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
CLOV currently screens at market cap $1.55B. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Not investment advice. Open the CLOV and KRYS stock pages for the full models.
Not investment advice.